消费者保健(CHC)市场检讨:2023年中间报告

本报告提供消费者保健(CHC)市场相关调查，彙整各市场分类的销售额实际成果和趋势，前12名市场(美国，中国，德国，巴西，义大利，印度等)的最新趋势，及今后的短期及2027年及到2032年为止的长期预测等资料。

范例视图

目录

全球概要

• 由于微观层面的重大变化，CHC 市场仍不稳定。
• 竞争状况
• 创新与新产品开发
• 处方药到非处方药的转换

各类别趋势

• 止痛药
• 咳嗽，感冒，过敏
• 肠胃
• 维他命，矿物，补充品
• 皮肤科
• 生活方式CHC

核心市场

• 概要
• 美国
• 中国
• 日本
• 俄罗斯
• 德国
• 法国
• 义大利
• 巴西
• 印度
• 英国
• 澳洲
• 墨西哥

预测

• 短期预测
• 长期预测

The report features the latest MAT Q2 2023 sales data from our dedicated DB6 database, including topline historical sales globally, by region, country and category, short-term forecasts to 2023-24 and long-term forecasts to 2027 & 2032.

Find out the very latest global, regional and market-level trends in CHC Access the newest sales data, freshly published by DB6 Read fresh analysis of category trends, brand activity and regulatory updates Get your hands on the most up-to-date short-term forecasts

Four concise chapters cover all the key insights you need:

SAMPLE VIEW

Nicholas Hall's “Mid-2023 CHC Review”, charts the very latest CHC sales, growth drivers and forecasts in a succinct topical review.

Over 90 detail-packed pages, it probes the most important CHC market influences globally, across categories and individual markets, while casting an eye to the future.

The report features the latest MAT Q2 2023 sales data from our dedicated DB6 database, including topline historical sales globally, by region, country and category, short-term forecasts to 2023-24 and long-term forecasts to 2027 & 2032.

Featuring sales for the 12-month period ending June 2023, plus y-o-y growth rates, the report includes over 60 unique sales charts. Historical growth rates 2019-22 are included to help chronicle performance fluctuations over time.

Global Overview delves into the CHC market's performance and tracks the latest happenings in Switch, Innovation, M&A and beyond.

Charts include:

• Global CHC sales mid-2022 & mid-2023¹
• Global CHC sales by region mid-2023²
• Global CHC sales by major category mid-2023²
• Global Top 10 CHC players mid-2023²

Covering all six major categories in turn, Category Trends charts the factors impacting Analgesics, CCA, GIs, VMS, Derma and Lifestyle CHC, casting the spotlight on individual subcategories.

Charts include:

• Global [major category] sales mid-2022 & mid-2023¹
• Global [major category] sales by subcategory mid-2023²
• Global leading [major category] brands mid-2023²

Core Markets assesses the most recent developments in each of the Top 12 markets (including USA, China, Germany, Brazil, Italy, India and more), appraising performances and trends category by category.

Charts include:

• Global leading CHC markets mid-2023²
• [Market] CHC sales mid-2022 & mid-2023¹
• [Market] CHC sales by major category mid-2023²
• [Market] leading marketers & brands mid-2023²

Evaluating the future of CHC, the Outlook chapter considers the prospects & challenges facing CHC players, alongside short- and long-term forecast sales.

Charts include:

• Global short-term forecast sales by
• major category / by region 2023-24
• Global 5 & 10 year forecast sales by
• major category / by region 2027 & 2032

¹including historical growth rates; ²including CAGR 22/18.

Table of Contents

Global Overview

• Key shifts at the micro-level see CHC market remain in flux
• Competitive landscape
• Innovation & NPD
• Rx-to-OTC switch

Category Trends

• Analgesics
• Cough, Cold & Allergy
• Gastrointestinals
• Vitamins, Minerals & Supplements
• Dermatologicals
• Lifestyle CHC

Core Markets

• Overview
• USA
• China
• Japan
• Russia
• Germany
• France
• Italy
• Brazil
• India
• UK
• Australia
• Mexico

Outlook

• Short-term forecast
• Long-term forecast